News 21 May 2026

Sera Prognostics Moves Up 15% Just Ahead of Holiday

Sera Prognostics Moves Up 15% Just Ahead of Holiday

Sera Prognostics shares jumped 15% to $2.07 Friday, trading over 530,000 shares—21 times the previous day’s volume—despite no new company disclosures. The move outpaced peers and came as Sera reported $14,000 in Q1 revenue, a net loss of $8.4 million, and $86.8 million in cash. Executives said 2026 revenue may stay “modest and uneven” as reimbursement and awareness efforts continue.
May 23, 2026
Fold Holdings Stock Nears $1 As New SEC Filings Put Share Supply In Focus

Fold Holdings Stock Nears $1 As New SEC Filings Put Share Supply In Focus

Fold Holdings shares slipped 0.8% to $1.26 after the company filed new prospectus supplements and reported annual-meeting results. CEO Will Reeves sold 20,362 shares to cover tax withholding, retaining 5.51 million. First-quarter revenue fell 21% to $5.6 million, with a net loss of $29.2 million. Shareholders elected two directors and ratified the auditor for 2026.
May 21, 2026
Atrium Therapeutics Stock Climbs: The Key FDA Filing Investors Are Watching Now

Atrium Therapeutics Stock Climbs: The Key FDA Filing Investors Are Watching Now

Atrium Therapeutics shares climbed 1.9% to $12.96 Thursday, valuing the company at about $222 million. The RNA drug developer expects to submit its first IND for ATR 1072, targeting PRKAG2 syndrome, in the second half of 2026. Atrium reported $267.8 million in cash at March 31, with all programs still preclinical. Leerink Partners initiated coverage last week with an outperform rating and $25 price target.
May 21, 2026
NewtekOne Stock Moves as Investors Watch Digital Bank Pivot

NewtekOne Stock Moves as Investors Watch Digital Bank Pivot

NewtekOne Inc. shares rose 1.1% to $13.40 Thursday after first-quarter earnings met 2026 guidance and deposits nearly doubled to $1.9 billion from a year earlier. The company reported EPS of $0.43, up from $0.36 last year. Loan production reached $391 million for the quarter. CEO Barry Sloane cited credit quality as a key concern on the earnings call.
May 21, 2026
Puma Biotechnology trades quietly in New York

Puma Biotechnology trades quietly in New York

Puma Biotechnology shares rose 0.3% to $7.01 on Thursday, trailing a 1.1% gain in the SPDR S&P Biotech ETF. The company last updated investors May 7, raising 2026 revenue guidance to $222–$229 million and net income to $16–$19 million. First-quarter revenue fell to $44.8 million, with a net loss of $3.8 million. Outstanding debt was paid off May 4.
May 21, 2026
Navient Shares Up as CEO Change Looms

Navient Shares Up as CEO Change Looms

Navient shares rose 2.7% to $8.53 Thursday afternoon, with no new company news. Trading volume reached about 354,000 shares. The move came as investors weighed earlier earnings, a $550 million securitization, and an upcoming CEO change set for June 5. Broader markets were higher, but sector peers showed mixed performance.
May 21, 2026
ATXG sticks close to $4 after fresh 13D holder shows up

ATXG sticks close to $4 after fresh 13D holder shows up

Addentax Group shares hovered near $4.30 Thursday after a 7.4% drop, as filings showed Or Shan Shan now owns 13.81% following Addentax’s all-stock acquisition of Time Is Loan Ltd. Another filing confirmed Addentax bought 62.18% of Keemo Fashion for $5.5 million. ATXG closed at $4.26 Wednesday on light volume. The company recently completed a 1-for-15 reverse stock split and posted a $4.7 million net loss for nine months.
May 21, 2026
GigCapital8 Shares Stay Flat at $10 as Deadline Nears

GigCapital8 Shares Stay Flat at $10 as Deadline Nears

GigCapital8 Corp. shares closed at $10.05 on Nasdaq, up one cent, with just 110 shares traded in a narrow range. The SPAC reported no operating revenue and $257.5 million in its trust account as of March 31. Its Class A shares trade under GIW, with a redemption value of $10.17 each. No business combination has been announced.
May 21, 2026
AYTU Stock Slips Before Exxua Update Investors Are Watching

AYTU Stock Slips Before Exxua Update Investors Are Watching

Aytu BioPharma shares fell 3% to $2.08 on Thursday after reporting a quarterly revenue drop to $12.4 million from $18.5 million a year earlier. Exxua, its new antidepressant, contributed $2.4 million, while legacy ADHD drug sales declined. The company will present at the Lytham Partners Spring 2026 Investor Conference on May 28. Cash and cash equivalents stood at $26.7 million at quarter-end.
May 21, 2026
Kolibri Global Energy Shares Dip Despite Oil Move

Kolibri Global Energy Shares Dip Despite Oil Move

Kolibri Global Energy shares fell 10 cents to $6.14 in midday Nasdaq trading Thursday, despite reporting record first-quarter net revenue of $19.6 million. Net income dropped to $4 million after a $2.9 million unrealized loss on commodity contracts. Oil prices climbed about 3% on renewed Iran supply concerns. Kolibri’s production averaged 4,685 BOEPD, with three new wells being drilled.
May 21, 2026
Corsair Shares Drop Despite Margin Recovery

Corsair Shares Drop Despite Margin Recovery

Corsair Gaming shares fell 1.5% to $6.78 Thursday morning in New York, lagging tech peers ahead of a June 4 investor meeting. March-quarter revenue dropped 4.1% to $354.5 million, but gross margin rose to 32.7%. Net income reached $13.1 million, reversing a loss last year. The company repurchased 0.9 million shares for $5 million in Q1.
May 21, 2026
WD-40 Down Ahead of Holiday Weekend

WD-40 Down Ahead of Holiday Weekend

WD-40 shares fell $2.71 to $205.30 late Thursday morning as consumer staples led S&P 500 sector losses and oil prices rose. The stock gave back part of Wednesday’s gain, trading about 1.3% below the prior close. WD-40 last reported higher quarterly sales and reaffirmed full-year guidance, but investors remain focused on cost and oil risks. Market value stood near $2.77 billion.
May 21, 2026
LSH Shares Fall After Profit Turnaround – Nasdaq Risk in Focus

LSH Shares Fall After Profit Turnaround – Nasdaq Risk in Focus

Lakeside Holding shares dropped 10.6% to $0.514 Thursday, valuing the company at $17.7 million and keeping it below Nasdaq’s $1 minimum with a July 7 compliance deadline. Quarterly revenue jumped 167% to $1.33 million, with net income of $142,408, but continuing operations posted a $1.58 million loss. The company has shifted focus to pharmaceutical distribution in China.
May 21, 2026
UBCP Stock Slips Despite Dividend Yield: What United Bancorp Investors Are Watching Now

UBCP Stock Slips Despite Dividend Yield: What United Bancorp Investors Are Watching Now

United Bancorp Inc. shares dropped 1.25% to $14.24 in late-morning trading Thursday on volume of 146 shares. The move comes ahead of a June 19 dividend payout of $0.195 per share, up 5.4% from last year. First-quarter net income rose 2.1% to $1.911 million, but nonaccrual and overdue loans climbed to $6.8 million. Noninterest expense increased 10.2%, partly due to office and digital investments.
May 21, 2026
1 4 5 6 7 8 337

Stock Market Today

  • 3 ASX Dividend Shares Yielding Up to 9% With Monthly Payouts
    May 22, 2026, 8:02 PM EDT. Three ASX-listed dividend shares offering monthly payouts are attracting income-focused investors seeking steady passive income. BetaShares Australian Top 20 Equity Yield Maximiser Fund (ASX: YMAX) delivers a 9% gross distribution yield, mainly invested in financials and materials sectors. Plato Income Maximiser Ltd (ASX: PL8), a listed investment company, pays fully-franked monthly dividends with a 4.8% yield, focusing on major ASX dividend stocks. Metrics Income Opportunities Trust (ASX: MOT), a listed investment trust investing in private credit and related assets, targets a 7% cash yield, offering monthly income and capital preservation. These options provide diversified income streams with frequent payouts for investors prioritizing regular cash flow.